Euphrates Vascular
St. Louis, US · Founded 2018 · Delaware corporation · 4 known investors
Founders & leadership
TL
Troy LongNamed on SEC filing
JB
Jeffrey BlairNamed on SEC filing
TB
Tim BlairNamed on SEC filing
EM
Eric MoessingerNamed on SEC filing
RM
Robert MitchellNamed on SEC filing
TH
Thomas HillmanNamed on SEC filing
Board
SM
Investors · 4
Reported raises · per SEC filings
Form D private placements$9.7M disclosed across 2 rounds · 2018–2020
▶$9.1MraisedOct 2023 · 33 investors · BiotechnologyRule 506(b)
▶$9.1MraisedOct 2023 · 33 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Cathy MatthesExecutive Officer
- Martin Omid AkhavanExecutive Officer, Director
- Sean MorrisDirector
- Offering amount
- $9.1M
- Amount sold
- $9.1M
- Minimum investment
- $5K
- Sales commissions
- $120.1K
- Placement agents
- CIM Securities LLC
- First sale
- Jul 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$590KraisedSep 2018 · 4 investors · BiotechnologyRule 506(b)
▶$590KraisedSep 2018 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Troy LongExecutive Officer
- Sean MorrisExecutive Officer, Director
- Jeffrey BlairDirector
- Tim BlairExecutive Officer
- Eric MoessingerDirector
- Robert MitchellDirector
- Thomas HillmanDirector
- Offering amount
- $4M
- Amount sold
- $590K
- Minimum investment
- $25K
- First sale
- Aug 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlapImperative Care Inc4 shared keywordsImperative Care develops medical technologies for treating stroke and other vascular diseases, aiming to address gaps across the patient care journey. The company focuses on devices and solutions for patients suffering from devastating vascular conditions.
AngioDynamics3 shared keywordsAngioDynamics develops and manufactures medical devices aimed at treating serious diseases and improving patient outcomes. Founded in 1988, the company serves healthcare professionals and operates globally across North America, Europe, the Middle East, and South America.
Mercator MedSystems3 shared keywordsMercator MedSystems develops catheter-based Micro-Infusion technologies, including the Bullfrog Micro-Infusion Device, for the local delivery of pharmacologic and biologic agents to the peripheral vasculature. The medical device company runs clinical studies in deep vein thrombosis and below-the-knee peripheral arterial disease, with applications in cardiovascular treatment and denervation for hypertension.
Bioworld3 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Companies competing with Euphrates Vascular for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- Who are Euphrates Vascular's investors?
- Euphrates Vascular's investors include Missouri Technology Corporation, OSF Ventures, View Ventures, Cultivation Capital.
- How much funding has Euphrates Vascular raised?
- Euphrates Vascular has disclosed $9.7M raised across 2 rounds.
- Where is Euphrates Vascular headquartered?
- Euphrates Vascular is headquartered in St. Louis, US.